Here's Why Inovio Pharmaceuticals Inc. Fell 21.3% in November
Shares of Inovio Pharmaceuticals Inc. (NASDAQ: INO), a biopharmaceutical company developing vaccines, fell 21.3% in November according to data from S&P Global Market Intelligence. Despite reporting some important pipeline progress investors weren't pleased with the company's widening losses.
Inovio Pharmaceuticals Inc.'s third-quarter loss grew 64% to $34.1 million from $20.8 million last year. Without product sales to smooth out the bumps, Inovio's top line is prone to exceptional lumpiness from one quarter to the next as it recognizes various one-time cash infusions from collaboration partners.
Image source: Getty Images.
Source: Fool.com
Inovio Pharma Stock
€0.53
-2.240%
Currently there is a rather negative sentiment for Inovio Pharma with 2 Buy predictions and 4 Sell predictions..
However, we have a potential of 1967.67% for Inovio Pharma as the target price of 11 € is above the current price of 0.53 €.
